FAM178B
gene geneOn this page
Also known as LOC51252
Summary
FAM178B (family with sequence similarity 178 member B, HGNC:28036) is a protein-coding gene on chromosome 2q11.2, encoding Protein FAM178B (Q8IXR5).
At a glance
- GWAS associations: 10
- Clinical variants (ClinVar): 37 total
- MANE Select transcript:
NM_001122646
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28036 |
| Approved symbol | FAM178B |
| Name | family with sequence similarity 178 member B |
| Location | 2q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LOC51252 |
| Ensembl gene | ENSG00000168754 |
| Ensembl biotype | protein_coding |
| Entrez | 51252 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding_CDS_not_defined, 2 protein_coding, 1 retained_intron
ENST00000393526, ENST00000470789, ENST00000478671, ENST00000490605, ENST00000494172, ENST00000520074
RefSeq mRNA: 3 — MANE Select: NM_001122646
NM_001122646, NM_001172667, NM_016490
CCDS: CCDS33252, CCDS46366
Canonical transcript exons
ENST00000490605 — 17 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001160740 | 96875885 | 96876308 |
| ENSE00001625042 | 96902620 | 96902707 |
| ENSE00001648149 | 96971901 | 96972322 |
| ENSE00001649546 | 96970716 | 96970777 |
| ENSE00001709577 | 96967520 | 96967627 |
| ENSE00001760721 | 96960288 | 96960440 |
| ENSE00001765239 | 96921478 | 96921654 |
| ENSE00001784614 | 96921165 | 96921262 |
| ENSE00001853587 | 96986241 | 96986580 |
| ENSE00003473682 | 96947818 | 96947902 |
| ENSE00003543521 | 96877890 | 96878042 |
| ENSE00003564204 | 96878416 | 96878493 |
| ENSE00003568560 | 96893926 | 96894051 |
| ENSE00003581444 | 96972538 | 96972606 |
| ENSE00003584816 | 96923490 | 96923583 |
| ENSE00003596569 | 96929206 | 96929320 |
| ENSE00003642817 | 96951379 | 96951484 |
Expression profiles
Bgee: expression breadth ubiquitous, 163 present calls, max score 89.35.
FANTOM5 (CAGE): breadth broad, TPM avg 0.9664 / max 52.4876, expressed in 213 samples.
FANTOM5 promoters (9 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 29787 | 0.3141 | 62 |
| 29788 | 0.2934 | 62 |
| 29790 | 0.1062 | 54 |
| 29789 | 0.0667 | 29 |
| 29814 | 0.0655 | 20 |
| 29797 | 0.0564 | 36 |
| 202306 | 0.0350 | 26 |
| 29815 | 0.0168 | 12 |
| 29813 | 0.0124 | 8 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| C1 segment of cervical spinal cord | UBERON:0006469 | 89.35 | gold quality |
| spinal cord | UBERON:0002240 | 87.07 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.90 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 84.51 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 84.44 | gold quality |
| tibial nerve | UBERON:0001323 | 82.67 | gold quality |
| kidney epithelium | UBERON:0004819 | 82.23 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.89 | gold quality |
| superficial temporal artery | UBERON:0001614 | 81.25 | gold quality |
| tibialis anterior | UBERON:0001385 | 80.34 | silver quality |
| bone marrow | UBERON:0002371 | 79.57 | gold quality |
| substantia nigra | UBERON:0002038 | 79.38 | gold quality |
| upper arm skin | UBERON:0004263 | 78.09 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 77.91 | gold quality |
| myocardium | UBERON:0002349 | 77.79 | gold quality |
| bone marrow cell | CL:0002092 | 77.75 | gold quality |
| midbrain | UBERON:0001891 | 77.71 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 77.56 | gold quality |
| putamen | UBERON:0001874 | 77.48 | gold quality |
| sural nerve | UBERON:0015488 | 76.39 | gold quality |
| cerebellar vermis | UBERON:0004720 | 75.64 | gold quality |
| spleen | UBERON:0002106 | 75.38 | gold quality |
| deltoid | UBERON:0001476 | 75.32 | gold quality |
| prefrontal cortex | UBERON:0000451 | 75.28 | gold quality |
| amygdala | UBERON:0001876 | 75.07 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 74.92 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 74.53 | gold quality |
| left testis | UBERON:0004533 | 74.37 | gold quality |
| right testis | UBERON:0004534 | 74.29 | gold quality |
| quadriceps femoris | UBERON:0001377 | 74.23 | gold quality |
Single-cell (SCXA)
Detected in 13 experiment(s), a significant marker in 12.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7407 | yes | 1568.28 |
| E-CURD-98 | yes | 1262.16 |
| E-CURD-112 | yes | 1136.47 |
| E-MTAB-10042 | yes | 1019.41 |
| E-ANND-5 | yes | 616.19 |
| E-GEOD-130473 | yes | 521.74 |
| E-MTAB-9067 | yes | 357.31 |
| E-HCAD-4 | yes | 142.03 |
| E-HCAD-8 | yes | 108.89 |
| E-HCAD-6 | yes | 45.04 |
| E-CURD-122 | yes | 22.80 |
| E-ANND-3 | yes | 8.28 |
| E-HCAD-10 | no | 1.92 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
26 targeting FAM178B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-125A-5P | 99.36 | 70.59 | 1640 |
| HSA-MIR-125B-5P | 99.36 | 70.36 | 1662 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
| HSA-MIR-4784 | 99.15 | 67.41 | 1733 |
| HSA-MIR-4270 | 99.02 | 66.26 | 1987 |
| HSA-MIR-3196 | 98.96 | 63.91 | 326 |
| HSA-MIR-3150B-3P | 98.81 | 67.21 | 1728 |
| HSA-MIR-9500 | 98.62 | 66.54 | 1845 |
| HSA-MIR-6754-5P | 98.60 | 65.54 | 1627 |
| HSA-MIR-6816-5P | 98.46 | 64.35 | 364 |
| HSA-MIR-5008-5P | 98.42 | 65.87 | 1019 |
| HSA-MIR-484 | 98.16 | 66.92 | 1074 |
| HSA-MIR-3155A | 98.16 | 66.09 | 965 |
| HSA-MIR-3155B | 98.16 | 66.09 | 965 |
| HSA-MIR-4649-5P | 93.02 | 63.85 | 141 |
| HSA-MIR-6729-5P | 93.02 | 62.76 | 138 |
| HSA-MIR-4508 | 90.37 | 59.62 | 240 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Fam178b | ENSMUSG00000046337 |
| rattus_norvegicus | Fam178b | ENSRNOG00000023941 |
Paralogs (1): SLF2 (ENSG00000119906)
Protein
Protein identifiers
Protein FAM178B — Q8IXR5 (reviewed: Q8IXR5)
All UniProt accessions (1): Q8IXR5
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the FAM178 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IXR5-3 | 3 | yes |
| Q8IXR5-2 | 2 | |
| Q8IXR5-4 | 4 |
RefSeq proteins (3): NP_001116118, NP_001166138, NP_057574 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026161 | FAM178 | Family |
| IPR044276 | CANIN_dom | Domain |
Pfam: PF14816
UniProt features (9 total): splice variant 3, sequence conflict 2, chain 1, region of interest 1, compositionally biased region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IXR5-F1 | 66.01 | 0.21 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 48 (showing top):
DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_DN, DARWICHE_PAPILLOMA_RISK_HIGH_DN, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, CAGCTG_AP4_Q5, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, AP1FJ_Q2, chr2q11, MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED, CHAF1B_TARGET_GENES, E2F5_TARGET_GENES, GREB1_TARGET_GENES, NFKBIA_TARGET_GENES, ZNF197_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
478 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM178B | FAHD2B | Q6P2I3 | 696 |
| FAM178B | ITPRIPL1 | Q6GPH6 | 593 |
| FAM178B | ANKRD39 | Q53RE8 | 590 |
| FAM178B | ANKRD36 | A6QL64 | 570 |
| FAM178B | CNNM3 | Q8NE01 | 541 |
| FAM178B | LCA5L | O95447 | 531 |
| FAM178B | CATSPERB | Q9H7T0 | 528 |
| FAM178B | CCDC60 | Q8IWA6 | 518 |
| FAM178B | FER1L5 | A0AVI2 | 506 |
| FAM178B | ANKRD36C | Q5JPF3 | 480 |
| FAM178B | ANKRD36B | Q8N2N9 | 461 |
| FAM178B | LMAN2L | Q9H0V9 | 447 |
| FAM178B | ZNF514 | Q96K75 | 446 |
| FAM178B | ASTL | Q6HA08 | 434 |
| FAM178B | RBKS | Q9H477 | 425 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF598 | FAM178B | psi-mi:“MI:0915”(physical association) | 0.000 |
| LRSAM1 | FAM178B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (2): FAM178B (Two-hybrid), FAM178B (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0JN53, A0PJX8, A1L1L2, A1L3T7, A4FV45, B0BMG8, E2JF22, G3HQ82, O15360, O43299, O70491, P60330, Q0KL00, Q0V8E7, Q17Q97, Q24JP3, Q3U829, Q49LS3, Q4QR83, Q562E7, Q5ND34, Q5R7B4, Q5T1A1, Q5XG04, Q6NUQ4, Q6PH58, Q6UX68, Q7L4E1, Q7Z412, Q8BGI5, Q8BM55, Q8BSD4, Q8BXV2, Q8C3R1, Q8C7B8, Q8IXR5, Q8K0R6, Q8N6S5, Q8R115, Q8VCA6
Diamond homologs: F1QB81, Q5REF4, Q6P9P0, Q8IX21, Q8IXR5, Q24JP3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
37 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
889 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:96878038:TCGCC:T | acceptor_gain | 1.0000 |
| 2:96878039:CGCC:C | acceptor_gain | 1.0000 |
| 2:96878039:CGCCC:C | acceptor_gain | 1.0000 |
| 2:96878041:CC:C | acceptor_gain | 1.0000 |
| 2:96878042:CC:C | acceptor_gain | 1.0000 |
| 2:96878415:CCCA:C | donor_gain | 1.0000 |
| 2:96876307:GCCTG:G | acceptor_loss | 0.9900 |
| 2:96876309:C:CC | acceptor_gain | 0.9900 |
| 2:96876309:CTG:C | acceptor_loss | 0.9900 |
| 2:96876310:T:A | acceptor_loss | 0.9900 |
| 2:96876315:C:CT | acceptor_gain | 0.9900 |
| 2:96877884:CACCA:C | donor_loss | 0.9900 |
| 2:96877885:ACCAC:A | donor_loss | 0.9900 |
| 2:96877886:CCACC:C | donor_loss | 0.9900 |
| 2:96877888:AC:A | donor_loss | 0.9900 |
| 2:96877889:C:CT | donor_loss | 0.9900 |
| 2:96877912:AGCT:A | donor_gain | 0.9900 |
| 2:96877915:T:TA | donor_gain | 0.9900 |
| 2:96877948:T:TA | donor_gain | 0.9900 |
| 2:96878040:GCC:G | acceptor_gain | 0.9900 |
| 2:96878041:CCCTG:C | acceptor_gain | 0.9900 |
| 2:96878043:C:CC | acceptor_gain | 0.9900 |
| 2:96878044:T:A | acceptor_loss | 0.9900 |
| 2:96878045:G:C | acceptor_gain | 0.9900 |
| 2:96878045:G:GC | acceptor_gain | 0.9900 |
| 2:96878052:C:CT | acceptor_gain | 0.9900 |
| 2:96878053:G:T | acceptor_gain | 0.9900 |
| 2:96878408:AGACT:A | donor_loss | 0.9900 |
| 2:96878409:GACT:G | donor_loss | 0.9900 |
| 2:96878410:ACT:A | donor_loss | 0.9900 |
AlphaMissense
4398 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:96877922:A:G | W659R | 0.989 |
| 2:96877922:A:T | W659R | 0.989 |
| 2:96902686:G:C | S528R | 0.989 |
| 2:96902686:G:T | S528R | 0.989 |
| 2:96902688:T:G | S528R | 0.989 |
| 2:96960371:A:C | F268L | 0.978 |
| 2:96960371:A:T | F268L | 0.978 |
| 2:96960373:A:G | F268L | 0.978 |
| 2:96878473:G:C | S599R | 0.975 |
| 2:96878473:G:T | S599R | 0.975 |
| 2:96878475:T:G | S599R | 0.975 |
| 2:96921489:A:G | W485R | 0.975 |
| 2:96921489:A:T | W485R | 0.975 |
| 2:96951390:A:G | W328R | 0.973 |
| 2:96951390:A:T | W328R | 0.973 |
| 2:96921212:G:C | N505K | 0.969 |
| 2:96921212:G:T | N505K | 0.969 |
| 2:96877920:C:A | W659C | 0.965 |
| 2:96877920:C:G | W659C | 0.965 |
| 2:96960372:A:G | F268S | 0.965 |
| 2:96960294:A:G | F294S | 0.961 |
| 2:96921487:C:A | W485C | 0.956 |
| 2:96921487:C:G | W485C | 0.956 |
| 2:96972114:G:C | F117L | 0.955 |
| 2:96972114:G:T | F117L | 0.955 |
| 2:96972116:A:G | F117L | 0.955 |
| 2:96877921:C:G | W659S | 0.953 |
| 2:96929303:A:G | W366R | 0.952 |
| 2:96929303:A:T | W366R | 0.952 |
| 2:96947901:A:G | L332P | 0.950 |
dbSNP variants (sampled 300 via entrez): RS1000061295 (2:96956929 C>A), RS1000077926 (2:96914127 G>A), RS1000131322 (2:96913962 A>C), RS1000153589 (2:96950476 G>A), RS1000188183 (2:96932416 A>G), RS1000214513 (2:96888445 G>A), RS1000231501 (2:96897011 C>A,T), RS1000258786 (2:96891066 A>C,G), RS1000336591 (2:96908988 C>A), RS1000337254 (2:96967206 A>C), RS1000353101 (2:96986606 C>A,T), RS1000354950 (2:96902350 C>T), RS1000355688 (2:96979923 T>C), RS1000384660 (2:96922164 G>C), RS1000395638 (2:96949187 A>AGT)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
10 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005081_1 | Bipolar disorder lithium response (continuous) or schizophrenia | 5.000000e-08 |
| GCST008151_83 | Waist circumference | 4.000000e-07 |
| GCST008160_116 | Waist circumference | 4.000000e-07 |
| GCST010697_1 | Cortical surface area (min-P) | 6.000000e-12 |
| GCST010698_17 | Subcortical volume (min-P) | 9.000000e-09 |
| GCST010699_105 | Brain morphology (min-P) | 2.000000e-11 |
| GCST010700_9 | Cortical thickness (MOSTest) | 9.000000e-14 |
| GCST010701_54 | Cortical surface area (MOSTest) | 2.000000e-16 |
| GCST010702_79 | Subcortical volume (MOSTest) | 5.000000e-09 |
| GCST010703_322 | Brain morphology (MOSTest) | 1.000000e-10 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB clinical annotations
1 annotations.
| Variant | Type | Level | Drugs | Phenotypes |
|---|---|---|---|---|
| rs6728642 | Efficacy | 3 | lithium | Bipolar Disorder |
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs6728642 | FAM178B | 3 | 0.00 | 1 | lithium |
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation | 2 |
| FR900359 | decreases phosphorylation | 1 |
| bisphenol A | affects cotreatment, increases methylation | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Arsenic | affects methylation | 1 |
| Folic Acid | decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Plant Extracts | decreases expression, affects cotreatment | 1 |
| Testosterone | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.